Valiant Organics Limited Holds 21st AGM on Sept 29, 2026; Discusses FY26 Performance
Valiant Organics Limited held its 21st AGM on September 29, 2026. For FY2025-26, the company reported revenue of ₹738.38 crore and PAT of ₹34.36 crore, up from a loss in the prior year. Key resolutions included director re-appointments and approval of related party transactions.
The AGM addressed routine corporate governance matters, financial performance review, and director re-appointments. While the improved financial results are positive, the outcomes discussed are standard for an AGM and do not represent a major new development.
The company reported a significant turnaround in profitability, moving from a loss to a substantial profit, and highlighted operational improvements and strategic priorities, which are positive indicators.
Valiant Organics Limited convened its 21st Annual General Meeting (AGM) on Tuesday, September 29, 2026, commencing at 11:30 A.M. IST, through Video Conferencing and Other Audio-Visual Means (VC/OAVM). The meeting saw the attendance of 51 Members.
During the AGM, the Chairperson, Shri Navin C. Shah, presented the company's operating and financial performance for the financial year ended March 31, 2026 (FY2025-26). Key highlights included revenue from operations of ₹738.38 crore, EBITDA of ₹100.80 crore (representing a 13.65% EBITDA margin), and a Profit After Tax of ₹34.36 crore, a significant improvement from a loss of ₹3.00 crore in the previous financial year. The company emphasized its focus on capacity utilization, operational efficiencies, higher-value products, import substitution, and prudent capital allocation.
Executive Director and Chief Financial Officer, Shri Mahek M. Chheda, provided a detailed presentation on the company's manufacturing capabilities, product portfolio, and financial performance. The AGM addressed several items of business, including the adoption of audited standalone and consolidated financial statements for FY2025-26, re-appointment of directors, ratification of cost auditor remuneration, shifting of the registered office, and revisions in the terms of appointment for managing and executive directors. Additionally, resolutions were passed for approving material related party transactions with entities including Aarti Industries Limited, Valiant Laboratories Limited, and others.
The meeting also facilitated e-voting, with a cut-off date of September 22, 2026, for determining eligibility. Remote e-voting commenced on September 25, 2026, and concluded on September 28, 2026, with provisions for e-voting during the AGM and for 30 minutes post-conclusion. The AGM proceedings concluded at 12:09 P.M. IST.
What to do with a filing like this
Valiant Organics Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Valiant Organics Limited. Read the original for the full detail.